Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core
摘要:
The selective inhibition of coagulation factor Xa has emerged as an attractive strategy for the discovery of novel antithrombotic agents. Here we describe highly potent benzamidine factor Xa inhibitors based on a vicinally-substituted heterocyclic core. (C) 2001 DuPont Pharmaceuticals Company. Published by Elsevier Science Ltd. All rights reserved.
[EN] NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS<br/>[FR] COMPOSES HETEROAROMATIQUES CONTENANT DE L'AZOTE, UTILISES EN TANT QU'INHIBITEURS DU FACTEUR Xa
申请人:DU PONT PHARMACEUTICALS COMPANY
公开号:WO1998028269A1
公开(公告)日:1998-07-02
(EN) The present application describes nitrogen containing heteroaromatics and derivatives thereof of formula (I) or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is N or NH and D may be C(=NH)NH2, which are useful as inhibitors of factor Xa.(FR) La présente invention se rapporte à des composés hétéroaromatiques contenant de l'azote et à des dérivés de tels composés représentés par la formule (I), ou à des sels ou bioprécurseurs pharmaceutiquement acceptables de ces composés utiles en tant qu'inhibiteurs du facteur Xa. Dans la formule (I), J est N ou NH et D peut être C(=NH)NH2.
NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS
申请人:Bristol-Myers Squibb Pharma Company
公开号:EP0946508B1
公开(公告)日:2009-09-23
US6020357A
申请人:——
公开号:US6020357A
公开(公告)日:2000-02-01
US6548512B1
申请人:——
公开号:US6548512B1
公开(公告)日:2003-04-15
Nitrogen containing heteroaromatics as factor Xa inhibitors
申请人:DuPont Pharmaceuticals Company
公开号:US06020357A1
公开(公告)日:2000-02-01
The present application describes nitrogen containing heteroaromatics and derivatives thereof of formula I: ##STR1## or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is N or NH and D may be C(.dbd.NH)NH.sub.2, which are useful as inhibitors of factor Xa.